Sloan Kettering Institute for Cancer Research, based in New York, and Juno Therapeutics have filed a complaint for declaratory judgment of patent infringement against Kite Pharma.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Kite Pharma, Sloan Kettering Institute for Cancer Research, Juno Therapeutics, patent, IPR, PTAB, USPTO,